NCT02561988 - (EXPLORER) Study of BLU-285 in Patients With Advanced Systemic Mastocytosis (AdvSM) and Relapsed or Refractory Myeloid Malignancies | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

March 10, 2016

Primary Completion Date

October 5, 2022

Study Completion Date

January 19, 2023

Conditions

Aggressive Systemic MastocytosisSystemic Mastocytosis-associated Hematologic Non-mast Cell DiseaseMast Cell LeukemiaRelapsed or Refractory Myeloid Malignancies

Interventions

DRUG

Avapritinib

Trial Locations (11)

10029

Mount Sinai Hospital, New York

19104

University of Pennsylvania, Philadelphia

30322

Emory University, Atlanta

48109

University of Michigan Health System, Ann Arbor

77030

MD Anderson Cancer Center, Houston

80045

University of Colorado Cancer Center, Denver

84112

Huntsman Cancer Institute, Salt Lake City

94305

Stanford Cancer Institute, Stanford

02215

Dana Farber Cancer Institute, Boston

G12 0XL

Beatson West of Scotland Cancer Centre, Glasgow

SE1 9RT

Guy's Hospital, London